Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 241

1.

Detection of the active components of calf thymus nuclear proteins (TNP), histones that are binding with high affinity to HIV-1 envelope proteins and CD4 molecules.

Mamikonyan G, Kiyatkin A, Movsesyan N, Mkrtichyan M, Ghochikyan A, Petrushina I, Hwang J, Ichim TE, Keledjian H, Agadjanyan MG.

Curr HIV Res. 2008 Jun;6(4):318-26.

PMID:
18691030
2.

Potential drug targets on the HIV-1 envelope glycoproteins, gp120 and gp41.

Huang L, Zhang L, Chen CH.

Curr Pharm Des. 2003;9(18):1453-62. Review.

PMID:
12769725
3.
4.

A recombinant allosteric lectin antagonist of HIV-1 envelope gp120 interactions.

McFadden K, Cocklin S, Gopi H, Baxter S, Ajith S, Mahmood N, Shattock R, Chaiken I.

Proteins. 2007 May 15;67(3):617-29.

PMID:
17348010
5.

A novel class of HIV-1 inhibitors that targets the viral envelope and inhibits CD4 receptor binding.

Wang HG, Williams RE, Lin PF.

Curr Pharm Des. 2004;10(15):1785-93. Review.

PMID:
15180540
6.

Anti-HIV agents targeting the interaction of gp120 with the cellular CD4 receptor.

Vermeire K, Schols D.

Expert Opin Investig Drugs. 2005 Oct;14(10):1199-212. Review.

PMID:
16185162
7.
8.

An alteration of human immunodeficiency virus gp41 leads to reduced CCR5 dependence and CD4 independence.

Taylor BM, Foulke JS, Flinko R, Heredia A, DeVico A, Reitz M.

J Virol. 2008 Jun;82(11):5460-71. doi: 10.1128/JVI.01049-07. Epub 2008 Mar 19.

9.

Alpha-defensins block the early steps of HIV-1 infection: interference with the binding of gp120 to CD4.

Furci L, Sironi F, Tolazzi M, Vassena L, Lusso P.

Blood. 2007 Apr 1;109(7):2928-35.

11.

Critical role of Arg59 in the high-affinity gp120-binding region of CD4 for human immunodeficiency virus type 1 infection.

Fontenot D, Jones JK, Hossain MM, Nehete PN, Vela EM, Dwyer VA, Jagannadha Sastry K.

Virology. 2007 Jun 20;363(1):69-78. Epub 2007 Feb 23.

12.

Epigallocatechin gallate, the main polyphenol in green tea, binds to the T-cell receptor, CD4: Potential for HIV-1 therapy.

Williamson MP, McCormick TG, Nance CL, Shearer WT.

J Allergy Clin Immunol. 2006 Dec;118(6):1369-74. Epub 2006 Oct 13.

PMID:
17157668
13.

Proteomic analysis of the cellular responses induced in uninfected immune cells by cell-expressed X4 HIV-1 envelope.

Molina L, Grimaldi M, Robert-Hebmann V, Espert L, Varbanov M, Devaux C, Granier C, Biard-Piechaczyk M.

Proteomics. 2007 Sep;7(17):3116-30.

PMID:
17676665
14.

Heparan sulfate targets the HIV-1 envelope glycoprotein gp120 coreceptor binding site.

Vivès RR, Imberty A, Sattentau QJ, Lortat-Jacob H.

J Biol Chem. 2005 Jun 3;280(22):21353-7. Epub 2005 Mar 28.

15.

Investigations using photo affinity labeled analogues confirm the binding between sCD4 and the PND of HIV-1, MN.

Dettin M, Scarinci C, Seraglia R, Di Bello C.

Biochem Biophys Res Commun. 1997 Dec 18;241(2):584-8.

PMID:
9425315
16.

Retrocyclin, an antiretroviral theta-defensin, is a lectin.

Wang W, Cole AM, Hong T, Waring AJ, Lehrer RI.

J Immunol. 2003 May 1;170(9):4708-16.

17.

Identification of CD4-independent HIV receptors on spermatozoa.

Bandivdekar AH, Velhal SM, Raghavan VP.

Am J Reprod Immunol. 2003 Oct;50(4):322-7.

PMID:
14672335
18.

Cell surface proteins binding to recombinant soluble HIV-1 and HIV-2 transmembrane proteins.

Ebenbichler CF, Röder C, Vornhagen R, Ratner L, Dierich MP.

AIDS. 1993 Apr;7(4):489-95.

PMID:
8507415
19.
20.

Detection of receptor-ligand interactions using surface plasmon resonance: model studies employing the HIV-1 gp120/CD4 interaction.

Brigham-Burke M, Edwards JR, O'Shannessy DJ.

Anal Biochem. 1992 Aug 15;205(1):125-31.

PMID:
1443549

Supplemental Content

Support Center